Back
Severn Trent plc - ADR Vs. Nektar Therapeutics Industry Stock Comparison
Sell
19
STRNY
Severn Trent plc - ADR
Last Price:
$35.35
Seasonality Move:
-1.04%
Buy
60
NKTR
Nektar Therapeutics
Last Price:
$26.74
Seasonality Move:
6.79%
Sell
19
Severn Trent plc - ADR (STRNY)
is a Sell
Is Severn Trent plc - ADR a Buy, Sell or Hold?
-
The current Severn Trent plc - ADR [STRNY] share price is $35.32. The Score for STRNY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
STRNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $27.43. The Score for NKTR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
STRNY Stock Price Chart
What is Severn Trent plc - ADR's stock price today?
-
The Severn Trent plc - ADR share price today is $35.32The current trend is moderately bullish and STRNY is experiencing slight buying pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $27.43Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
STRNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.88 | Buy |
| Relative Strength Index (14 RSI): | 42.82 | Sell |
| Chaikin Money Flow: | 3156 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.27 - 36.63) | Sell |
| Bollinger Bands (100): | (34.4 - 37.5) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.2 | Buy |
| Relative Strength Index (14 RSI): | 66.48 | Buy |
| Chaikin Money Flow: | 48104 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.47 - 25.77) | Buy |
| Bollinger Bands (100): | (8.36 - 22.9) | Buy |
STRNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.48 | Sell |
| 20-day SMA: | 35.95 | Sell |
| 50-day SMA: | 36.52 | Sell |
| 200-day SMA: | 34.14 | Buy |
| 8-day EMA: | 34.86 | Buy |
| 20-day EMA: | 28.41 | Buy |
| 50-day EMA: | 16.84 | Buy |
| 200-day EMA: | 5.27 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.75 | Buy |
| 20-day SMA: | 23.93 | Buy |
| 50-day SMA: | 21.17 | Buy |
| 200-day SMA: | 15.14 | Buy |
| 8-day EMA: | 25.46 | Buy |
| 20-day EMA: | 24.2 | Buy |
| 50-day EMA: | 21.4 | Buy |
| 200-day EMA: | 16.73 | Buy |
Severn Trent plc - ADR Earnings Growth & STRNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.
Severn Trent plc - ADR Technical Analysis
| Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||